MYC and leukemia: Among these shared pathways, 76% (543 out of 717) overlapped in MOLM13 compared with K562 cells treated with Ro, which included c-MYC, mRNA-related, and leukemia-associated gene sets (Fig. 5d and Supplementary Data 12).